The Morality of Risks in Research: Reflections on Kumar

Abstract

Ethical requirements for a favorable risk/benefit ratio in clinical research reveal significant tensions within Kantian ethics and contractualist moral theory. Treating research participants as ends in themselves diverges from merely avoiding using them as causal means, since voluntary consent can render the assumption of interpersonal risks reasonable even in the absence of direct personal benefit. While an ex post contractualist framework excessively restricts permissible risk-imposing activities by equating small ex ante risks with certain eventual harms, an ex ante alternative struggles both to differentiate voluntary from involuntary exposures and to prevent scenarios where cumulative experimental harms exceed the burdens of the target disease. Furthermore, the non-instrumental expressive value of participating in research cannot independently justify enrollment when divorced from underlying risk magnitudes under conditions of empirical uncertainty. Finally, restricting willing individuals from entering high-risk trials lacking favorable risk/benefit ratios does not necessarily constitute paternalistic interference with liberty. Instead, such boundaries represent a researcher’s legitimate, non-paternalistic refusal to become complicit in inflicting avoidable harm. – AI-generated abstract.